157 related articles for article (PubMed ID: 16003491)
1. Histones as tumour suppressor genes.
Zaid O; Downs JA
Cell Mol Life Sci; 2005 Aug; 62(15):1653-6. PubMed ID: 16003491
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic analysis in the search for tumor suppressor genes.
Han ZG
Epigenomics; 2010 Aug; 2(4):489-93. PubMed ID: 22121966
[No Abstract] [Full Text] [Related]
3. Epigenetic inactivation of tumour suppressor coding and non-coding genes in human cancer: an update.
Llinàs-Arias P; Esteller M
Open Biol; 2017 Sep; 7(9):. PubMed ID: 28931650
[TBL] [Abstract][Full Text] [Related]
4. Histone H1 alterations in cancer.
Scaffidi P
Biochim Biophys Acta; 2016 Mar; 1859(3):533-9. PubMed ID: 26386351
[TBL] [Abstract][Full Text] [Related]
5. Histones, nucleosomes and transcription.
Svaren J; Hörz W
Curr Opin Genet Dev; 1993 Apr; 3(2):219-25. PubMed ID: 8389216
[TBL] [Abstract][Full Text] [Related]
6. Bringing H2AX into the angiogenesis family.
Rankin EB; Giaccia AJ; Hammond EM
Cancer Cell; 2009 Jun; 15(6):459-61. PubMed ID: 19477424
[TBL] [Abstract][Full Text] [Related]
7. Male germline-specific histones in mouse and man.
Churikov D; Zalenskaya IA; Zalensky AO
Cytogenet Genome Res; 2004; 105(2-4):203-14. PubMed ID: 15237208
[TBL] [Abstract][Full Text] [Related]
8. Transcription analysis of a histones modifiers panel coupled with critical tumor suppressor genes displayed frequent changes in patients with AML.: mRNA levels of histones modifiers and TSGs in AML.
Amiri V; Mohammadi MH; Rafiee M; Ghezelbash B; Salari S; Allahbakhshian Farsani M
Curr Res Transl Med; 2021 Oct; 69(4):103311. PubMed ID: 34455155
[TBL] [Abstract][Full Text] [Related]
9. Chromosomal proteins in transformed and neoplastic cells: a review.
Stein GS; Stein JL; Thomson JA
Cancer Res; 1978 May; 38(5):1181-201. PubMed ID: 639052
[No Abstract] [Full Text] [Related]
10. PAUPAR lncRNA suppresses tumourigenesis by H3K4 demethylation in uveal melanoma.
Ding X; Wang X; Lin M; Xing Y; Ge S; Jia R; Zhang H; Fan X; Li J
FEBS Lett; 2016 Jun; 590(12):1729-38. PubMed ID: 27214741
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic regulation in cancer development.
Caffarelli E; Filetici P
Front Biosci (Landmark Ed); 2011 Jun; 16(7):2682-94. PubMed ID: 21622203
[TBL] [Abstract][Full Text] [Related]
12. Histone H2B subtypes are dispensable during the yeast cell cycle.
Rykowski MC; Wallis JW; Choe J; Grunstein M
Cell; 1981 Aug; 25(2):477-87. PubMed ID: 7026046
[No Abstract] [Full Text] [Related]
13. Dominant-negative histone H3 lysine 27 mutant derepresses silenced tumor suppressor genes and reverses the drug-resistant phenotype in cancer cells.
Abbosh PH; Montgomery JS; Starkey JA; Novotny M; Zuhowski EG; Egorin MJ; Moseman AP; Golas A; Brannon KM; Balch C; Huang TH; Nephew KP
Cancer Res; 2006 Jun; 66(11):5582-91. PubMed ID: 16740693
[TBL] [Abstract][Full Text] [Related]
14. News about old histones: a role for histone age in controlling the epigenome.
van Leeuwen F; Frederiks F; Terweij M; De Vos D; Bakker BM
Cell Cycle; 2012 Jan; 11(1):11-2. PubMed ID: 22157090
[No Abstract] [Full Text] [Related]
15. Momentum building for human epigenome project.
Garber K
J Natl Cancer Inst; 2006 Jan; 98(2):84-6. PubMed ID: 16418505
[No Abstract] [Full Text] [Related]
16. Preparation of nucleosome core particle from recombinant histones.
Luger K; Rechsteiner TJ; Richmond TJ
Methods Enzymol; 1999; 304():3-19. PubMed ID: 10372352
[No Abstract] [Full Text] [Related]
17. The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression.
Babbio F; Pistore C; Curti L; Castiglioni I; Kunderfranco P; Brino L; Oudet P; Seiler R; Thalman GN; Roggero E; Sarti M; Pinton S; Mello-Grand M; Chiorino G; Catapano CV; Carbone GM; Bonapace IM
Oncogene; 2012 Nov; 31(46):4878-87. PubMed ID: 22330138
[TBL] [Abstract][Full Text] [Related]
18. Toxoplasma gondii has two lineages of histones 2b (H2B) with different expression profiles.
Dalmasso MC; Echeverria PC; Zappia MP; Hellman U; Dubremetz JF; Angel SO
Mol Biochem Parasitol; 2006 Jul; 148(1):103-7. PubMed ID: 16621068
[No Abstract] [Full Text] [Related]
19. Synergism between DNA methylation and macroH2A1 occupancy in epigenetic silencing of the tumor suppressor gene p16(CDKN2A).
Barzily-Rokni M; Friedman N; Ron-Bigger S; Isaac S; Michlin D; Eden A
Nucleic Acids Res; 2011 Mar; 39(4):1326-35. PubMed ID: 21030442
[TBL] [Abstract][Full Text] [Related]
20. Epigenetics provides a new generation of oncogenes and tumour-suppressor genes.
Esteller M
Br J Cancer; 2006 Jan; 94(2):179-83. PubMed ID: 16404435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
